MNKD Message Board Post 9183192 | MannKind Corporation
home / stock / mnkd / mnkd message board
haimkoskas
(investorshub)
Posted on: Apr/03/2021 15:27:21
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162960555
I wonder if Tyvaso would help in post
News, Short Squeeze, Breakout and More Instantly...
-
17-week endpoint results comparing Afrezza® head-to-head with multiple daily injections (MDI) and insulin pumps INHALE-3 Study Protocol Chai...
-
17-week endpoint results comparing Afrezza ® head-to-head with multiple daily injections (MDI) and insulin pumps INHALE-3 Study Protocol Chair Dr. Irl. B. Hirsh joined by investigational team to deliver presentation moderated by Jaeb Center founder Dr. Roy W. Beck ...
-
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation PR Newswire Cross license involves Pulmatrix iSPERSE™ technology and MannKind's Cricket ® inhalation device. Pulmatrix transferring leased building,...